Sunitinib Malate
- 1 January 2012
- book chapter
- Published by Elsevier
- Vol. 37, 363-388
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography–electrospray ionization-tandem mass spectrometry and pharmacokinetic applicationJournal of Pharmaceutical and Biomedical Analysis, 2010
- A routine feasible HPLC analysis for the anti-angiogenic tyrosine kinase inhibitor, sunitinib, and its main metabolite, SU12662, in plasmaJournal of Chromatography B, 2009
- Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometryJournal of Chromatography B, 2009
- Sunitinib (Sutent, SU11248), a Small-Molecule Receptor Tyrosine Kinase Inhibitor, Blocks Function of the ATP-Binding Cassette (ABC) Transporters P-Glycoprotein (ABCB1) and ABCG2Drug Metabolism and Disposition, 2009
- Pharmacokinetics of sunitinib in an obese patient with a GISTAnnals of Oncology, 2009
- Quantification of sunitinib in human plasma by high-performance liquid chromatography–tandem mass spectrometry☆Journal of Chromatography B, 2008
- Pharmacokinetics of sunitinib in hemodialysisAnnals of Oncology, 2008
- Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and MetoprololClinical Pharmacokinetics, 2005
- Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 2003
- Formation of Dihydropyridone- and Pyridone-Based Peptide Analogs through Aza-Annulation of β-Enamino Ester and Amide Substrates with α-Amido Acrylate DerivativesThe Journal of Organic Chemistry, 1997